Objective: We describe a prenatal molecular diagnosis of hypochondroplasia (HCH) in a pregnancy not at risk of HCH and review the literature on prenatal diagnosis of HCH. Case report: A 28-year-old primigravid woman was referred for genetic counseling at 30 weeks of gestation because of short-limbed dwarfism in the fetus. The woman had a body height of 152 cm. Her husband had a body height of 180 cm. Level II ultrasound showed a normal amount of amniotic fluid and a singleton fetus with fetal biometry equivalent to 30 weeks except for short limbs. Fetal biometry measurements were as follows: biparietal diameter ¼ 7.38 cm (30 weeks); head circumference ¼ 28.14 cm (30 weeks); abdominal circumference (AC) ¼ 24.64 cm (30 weeks); femur length (FL) ¼ 3.97 cm (<5th centile); FL/AC ratio ¼ 0.161 (normal > 0.18); humerus ¼ 3.64 cm (<5th centile); radius ¼ 3.49 cm (30 weeks); ulna ¼ 3.76 cm (<5 th centile); tibia ¼ 3.67 cm (<5th centile); and fibula ¼ 3.72 cm (<5th centile). The digits and craniofacial appearance were normal. A tentative diagnosis of achondroplasia (ACH) was made. DNA testing for the FGFR3 gene and whole-genome array comparative genomic hybridization (aCGH) analysis were performed using cord blood DNA obtained by cordocentesis. FGFR3 mutation analysis revealed a de novo heterozygous c.833A > G, TAC > TGC transversion in exon 7 leading to a p.Tyr278Cys (Y278C) mutation in the FGFR3 protein. aCGH analysis revealed no genomic imbalance in cord blood. After delivery, the fetus had short limbs, a narrow thorax, brachydactyly, and relative macrocephaly. Cytogenetic analysis of cultured placental cells revealed a karyotype of 46,XX. Conclusion: Prenatal diagnosis of abnormal ultrasound findings suspicious of ACH should include a differential diagnosis of HCH by molecular analysis of FGFR3.
Introduction
Hypochondroplasia (HCH; OMIM 146000) is an autosomal dominant skeletal dysplasia caused by mutations in the FGFR3 gene. FGFR3 (OMIM 134934) encodes fibroblast growth factor receptor 3 and is located at 4p16.3. A heterozygous FGFR3 N540K mutation accounts for 70% of all reported patients [1, 2] . HCH is characterized by short-limbed dwarfism, broad short hands and feet, mild joint laxity, macrocephaly, and roentgenographic findings of narrow inferior lumbar interpedicular distances, short long bones with mild metaphyseal flare, a short broad femur neck, and short square ilia [3] . Prenatal molecular diagnosis of HCH in a pregnancy not at risk of HCH is uncommon. Here, we present our experience of prenatal diagnosis of a de novo FGFR3 Y278C mutation in a pregnancy with fetal severe HCH and review the literature on prenatal diagnosis of HCH.
Case report
A 28-year-old primigravid woman was referred for genetic counseling at 30 weeks of gestation because of short-limbed dwarfism in the fetus. The woman had a body height of 152 cm. Her husband was 30 years old and had a body height of 180 cm. Both were healthy and unrelated, and there was no family history of congenital malformations. The prenatal ultrasound was unremarkable until 28 weeks of gestation, when a short femur was noted, with a femur length (FL) of 3.9 cm equivalent to 24 weeks. The biparietal diameter (BPD) was 7.3 cm (28 weeks), abdominal circumference (AC) was 23.7 cm (28 weeks), and the FL/AC ratio was 0.165. Level II ultrasound at 30 weeks of gestation showed a normal amount of amniotic fluid and a singleton fetus with fetal biometry equivalent to 30 weeks except for short limbs. Fetal biometry measurements were as follows (30-week 5the95th centile range): BPD ¼ 7.38 cm (7.30e8.20 cm); head circumference (HC) ¼ 28.14 cm (26.6e30.9 cm); AC ¼ 24.64 cm (21.7e27.4 cm); FL ¼ 3.97 cm (5.20e6.20 cm); HC/AC ¼ 1.14 (0.97e1.18); HC/FL ¼ 7.09 (4.54e5.38); FL/AC ¼ 0.161 (normal > 0.18); humerus ¼ 3.64 cm (4.4e5.6 cm); radius ¼ 3.49 cm (3.4e4.9 cm); ulna ¼ 3.76 cm (3.8e5.4 cm); tibia ¼ 3.67 cm (4.1e5.6 cm); and fibula ¼ 3.72 cm (3.8e5.2 cm). The digits and craniofacial appearance were normal. A tentative diagnosis of achondroplasia (ACH) was made. DNA testing for the FGFR3 gene and whole-genome array comparative genomic hybridization (aCGH) analysis were performed using cord blood DNA obtained by cordocentesis. FGFR3 mutation analysis revealed a de novo heterozygous c.833A > G, TAC > TGC transversion in exon 7 leading to a p.Tyr278Cys (Y278C) mutation in the FGFR3 protein (Fig. 1 ). Mutation analysis of parental blood samples did not reveal this mutation (Fig. 1) . aCGH analysis revealed no genomic imbalance in cord blood. A 1586-g fetus was delivered at 31 weeks of gestation with a body length of 41 cm. The fetus had short limbs, a narrow thorax, brachydactyly, and relative macrocephaly (Fig. 2) . Cytogenetic analysis of cultured placental cells revealed a karyotype of 46,XX. 
Discussion
The present case was associated with a de novo heterozygous Y278C mutation in FGFR3 and HCH. The patient carried a single base substitution (c.833A > G, TAC > TGC) that substitutes tyrosine 278 with cysteine (Y278C) in the first half of the third immunoglobulin-like loop of FGFR3. Approximately 70% of patients affected with HCH have a heterozygous mutation in FGFR3, and w72% of patients with FGFR3 mutations have N540K (Asn540Lys) resulting from FGFR3 Other rare mutations include S84L [9] , R200C [9] , N262H [9] , G268C [9] , Y278C [9] , L324V [10] , N328I [11] , G342C [12] , V381E [9] , I538V [13] , N540S [14, 15] , N540T [16] , K650N [17] , K650Q [9, 18] , and K652Q [17] . In a study of 74 patients with HCH, Heuertz et al found 10 (14%) familial cases and 64 (86%) sporadic cases with the following mutations: N540K (63.5%; 47 cases), K650Q (1.4%; 1 case), N328I (1.4%; 1 case); novel mutations of S84L, R200C, N262H, G268C, Y278C and V381E (8%; 6 cases); and no FGFR3 mutation (25.7%; 19 cases) [9] . Heuertz et al first reported a Y278C FGFR3 mutation in a patient with severe HCH [9] . The patient had a phenotype of ACH at birth, manifest as rhizomelic dwarfism, macrocephaly with midface hypoplasia, thoracolumbar kyphosis, short trident hands, and mild hypotonia at the age of 6 months; and a phenotype of HCH with normal craniofacial features, small stature with relatively short upper arms and thighs, and lumbar hyperlordosis at the age of 3.5 years.
To date, at least 12 cases of HCH with prenatal diagnosis have been reported [12,19e27] . Table 1 lists the FGFR3 mutations and prenatal and postnatal findings for 13 cases of HCH with prenatal diagnosis, including the present case. Among the 13 cases, six were sporadic and seven were familial, of which three involved paternal HCH [19, 21, 22] and four involved maternal HCH [12, 26, 27] . Five cases were carried to term delivery [20e24]. In the two cases with ACH and HCH in either parent, the parents decided to continue with the pregnancy even though prenatal ultrasound and/or molecular genetic analysis confirmed familial inherited skeletal dysplasia [21, 22] . The data in Table 1 show that fetuses with HCH can present with a short femur and humerus, relative macrocephaly, and an FL/AC ratio <0.18 in late second trimester without the associated abnormalities of ventriculomegaly, congenital heart defects, polydactyly, narrow thorax, and polyhydramnios. Prenatal findings for HCH are very similar to those for ACH. Therefore, prenatal diagnosis of abnormal ultrasound findings suspicious of ACH should include a differential diagnosis of HCH by molecular analysis of FGFR3 G380R and N540K mutations and other rare FGFR3 mutations associated with ACH and HCH if necessary. In the present case, the mother had a short stature but no molecular evidence of HCH. Prenatal diagnosis of short-limbed dwarfism in the presence of parental short stature other than ACH should raise a suspicion of familial HCH. For instance, Stoll et al reported prenatal diagnosis of paternally inherited HCH with a paternal height of 134 cm [19] and Wang et al reported prenatal diagnosis of maternally inherited HCH with a maternal height of 131 cm [12] . Prenatal diagnosis of HCH can be achieved by molecular analysis of fetal DNA extracted from amniotic fluid cells [19, 24, 25] , chorionic villi cells [26, 27] , cord blood lymphocytes (present case), or single-cell analysis by blastomere biopsy [27] . Park et al reported on a successful pregnancy and birth with preimplantation genetic diagnosis using single-cell PCR and sequencing in a 27-year-old woman with HCH, FGFR3 N540K mutation, and two consecutive abortions of HCH-affected fetuses diagnosed by molecular sequencing of chorionic villus samples [27] .
In summary, we have described prenatal molecular diagnosis of a de novo Y278C FGFR3 mutation in a pregnancy with fetal severe HCH and reviewed the literature on prenatal diagnosis of HCH. We emphasize the importance of molecular analysis of the FGFR3 gene in prenatally detected shortlimbed dwarfism suspicious of ACH and HCH.
